Effects of dietary L-arginine on nitric oxide bioavailability in obese normotensive and obese hypertensive subjects

Beverly Giam, Sanjaya Kuruppu, Geoffrey A. Head, David M. Kaye, Niwanthi W. Rajapakse

Research output: Contribution to journalComment / DebateOtherpeer-review

2 Citations (Scopus)

Abstract

Obesity related hypertension is a major risk factor for resistant hypertension. We do not completely understand the mechanism(s) underlying the development of obesity related hypertension which hinders the development of novel treatment strategies for this condition. Data from experimental studies and small clinical trials indicate that transport of L-arginine, the substrate for nitric oxide (NO), and subsequent NO production are reduced in obesity induced hypertension. Reduced NO bioavailability can induce hypertension via multiple mechanisms. Mirmiran et al. recently analyzed data from a large population study and found that the association between dietary L-arginine and serum nitrate and nitrite was weakened in obese hypertensive subjects compared to obese normotensives. These data suggest that L-arginine dependent NO production is impaired in the former group compared to the latter which may represent a novel mechanism contributing to hypertension in the setting of obesity.

Original languageEnglish
Article number364
JournalNutrients
Volume8
Issue number6
DOIs
Publication statusPublished - 14 Jun 2016

Keywords

  • L-arginine transport
  • Nitric oxide
  • Obesity related hypertension

Cite this

@article{5aa821fa684d4bf3885584126e3448b8,
title = "Effects of dietary L-arginine on nitric oxide bioavailability in obese normotensive and obese hypertensive subjects",
abstract = "Obesity related hypertension is a major risk factor for resistant hypertension. We do not completely understand the mechanism(s) underlying the development of obesity related hypertension which hinders the development of novel treatment strategies for this condition. Data from experimental studies and small clinical trials indicate that transport of L-arginine, the substrate for nitric oxide (NO), and subsequent NO production are reduced in obesity induced hypertension. Reduced NO bioavailability can induce hypertension via multiple mechanisms. Mirmiran et al. recently analyzed data from a large population study and found that the association between dietary L-arginine and serum nitrate and nitrite was weakened in obese hypertensive subjects compared to obese normotensives. These data suggest that L-arginine dependent NO production is impaired in the former group compared to the latter which may represent a novel mechanism contributing to hypertension in the setting of obesity.",
keywords = "L-arginine transport, Nitric oxide, Obesity related hypertension",
author = "Beverly Giam and Sanjaya Kuruppu and Head, {Geoffrey A.} and Kaye, {David M.} and Rajapakse, {Niwanthi W.}",
year = "2016",
month = "6",
day = "14",
doi = "10.3390/nu8060364",
language = "English",
volume = "8",
journal = "Nutrients",
issn = "2072-6643",
publisher = "MDPI",
number = "6",

}

Effects of dietary L-arginine on nitric oxide bioavailability in obese normotensive and obese hypertensive subjects. / Giam, Beverly; Kuruppu, Sanjaya; Head, Geoffrey A.; Kaye, David M.; Rajapakse, Niwanthi W.

In: Nutrients, Vol. 8, No. 6, 364, 14.06.2016.

Research output: Contribution to journalComment / DebateOtherpeer-review

TY - JOUR

T1 - Effects of dietary L-arginine on nitric oxide bioavailability in obese normotensive and obese hypertensive subjects

AU - Giam, Beverly

AU - Kuruppu, Sanjaya

AU - Head, Geoffrey A.

AU - Kaye, David M.

AU - Rajapakse, Niwanthi W.

PY - 2016/6/14

Y1 - 2016/6/14

N2 - Obesity related hypertension is a major risk factor for resistant hypertension. We do not completely understand the mechanism(s) underlying the development of obesity related hypertension which hinders the development of novel treatment strategies for this condition. Data from experimental studies and small clinical trials indicate that transport of L-arginine, the substrate for nitric oxide (NO), and subsequent NO production are reduced in obesity induced hypertension. Reduced NO bioavailability can induce hypertension via multiple mechanisms. Mirmiran et al. recently analyzed data from a large population study and found that the association between dietary L-arginine and serum nitrate and nitrite was weakened in obese hypertensive subjects compared to obese normotensives. These data suggest that L-arginine dependent NO production is impaired in the former group compared to the latter which may represent a novel mechanism contributing to hypertension in the setting of obesity.

AB - Obesity related hypertension is a major risk factor for resistant hypertension. We do not completely understand the mechanism(s) underlying the development of obesity related hypertension which hinders the development of novel treatment strategies for this condition. Data from experimental studies and small clinical trials indicate that transport of L-arginine, the substrate for nitric oxide (NO), and subsequent NO production are reduced in obesity induced hypertension. Reduced NO bioavailability can induce hypertension via multiple mechanisms. Mirmiran et al. recently analyzed data from a large population study and found that the association between dietary L-arginine and serum nitrate and nitrite was weakened in obese hypertensive subjects compared to obese normotensives. These data suggest that L-arginine dependent NO production is impaired in the former group compared to the latter which may represent a novel mechanism contributing to hypertension in the setting of obesity.

KW - L-arginine transport

KW - Nitric oxide

KW - Obesity related hypertension

UR - http://www.scopus.com/inward/record.url?scp=84975044125&partnerID=8YFLogxK

U2 - 10.3390/nu8060364

DO - 10.3390/nu8060364

M3 - Comment / Debate

VL - 8

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 6

M1 - 364

ER -